Last $9.38 USD
Change Today +0.34 / 3.76%
Volume 812.0K
SZYM On Other Exchanges
Symbol
Exchange
NASDAQ GS
Berlin
As of 8:10 PM 08/29/14 All times are local (Market data is delayed by at least 15 minutes).

solazyme inc (SZYM) Snapshot

Open
$9.05
Previous Close
$9.04
Day High
$9.39
Day Low
$9.02
52 Week High
03/12/14 - $15.00
52 Week Low
11/25/13 - $8.00
Market Cap
738.2M
Average Volume 10 Days
617.4K
EPS TTM
$-1.97
Shares Outstanding
78.7M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for SOLAZYME INC (SZYM)

solazyme inc (SZYM) Related Businessweek News

View More BusinessWeek News

solazyme inc (SZYM) Details

Solazyme, Inc. manufactures and sells renewable oils and other bioproducts. Its proprietary technology transforms a range of plant-based sugars into triglyceride oils and other bioproducts. The company offers renewable tailored oils, such as oleic oils that provide sustainable solutions within the food, lubricant, functional fluid, and oleo chemical markets; and drop-in replacements and blend stocks for marine, motor vehicle and jet fuels, as well as replacements for petrochemicals. It is also provides fuels, including SoladieselBD, a fatty acid methyl ester; SoladieselRD, a hydro-treated renewable diesel; SoladieselHRD-76, a military grade hydrotreated renewable diesel; and SolajetD7566 and SolajetHRJ-5 that are commercial and military grade hydrotreated renewable jets. In addition, the company offers microalgae-based food ingredients consisting of tailored oils and whole algal powders that enhance the nutritional profile and functionality of food products; and powdered ingredients comprising whole algal flour, whole algal protein, and golden chlorella high protein. Additionally, it provides skin and personal care products under the Algenist brand name, which include concentrated reconstructing serum, an anti-aging serum; complete eye renewal balm; firming and lifting cream, an anti-aging moisturizing cream; advanced anti-aging repairing oil, a face oil formulation; and genius cream. The company was incorporated in 2003 and is headquartered in South San Francisco, California.

271 Employees
Last Reported Date: 03/14/14
Founded in 2003

solazyme inc (SZYM) Top Compensated Officers

Co-Founder, Chief Executive Officer and Direc...
Total Annual Compensation: $545.0K
Chief Financial Officer, Chief Operating Offi...
Total Annual Compensation: $360.7K
Senior Vice President, General Counsel and Co...
Total Annual Compensation: $321.4K
Chief Technology Officer
Total Annual Compensation: $360.7K
Strategic Advisor
Total Annual Compensation: $412.0K
Compensation as of Fiscal Year 2013.

solazyme inc (SZYM) Key Developments

Solazyme and AkzoNobel Expand Joint Development Agreement

Solazyme, Inc. and Akzo Nobel N.V. have expanded their previous joint development agreement. The expansion provides for funded development, as well as agreed key terms for a multi-year supply agreement targeting annual supply of up to 10,000 MT of renewable Tailored algal oils, pending successful product development. The parties expect that the algal oil under the joint development agreement would be able to replace both petroleum and palm oil-derived chemicals. The target product is designed to have improved functional and environmental performance, as well as a lower overall cost to AkzoNobel.

Solazyme, Inc. Presents at 16th Annual Pacific Crest Global Technology Leadership Forum, Aug-12-2014 02:30 PM

Solazyme, Inc. Presents at 16th Annual Pacific Crest Global Technology Leadership Forum, Aug-12-2014 02:30 PM. Venue: The Sonnenalp Hotel, 20 Vail Road, Vail, CO 81657, United States.

Solazyme, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2014

Solazyme, Inc. reported unaudited consolidated earnings results for the second quarter and six months ended June 30, 2014. Total revenue for the second quarter of 2014 was $15.9 million compared with $11.2 million in the second quarter of 2013, an increase of 43%. Second quarter GAAP net loss was $42.9 million, which compares with net loss of $25.8 million in the prior year period. On a non-GAAP basis, the net loss was $32.9 million for the second quarter of 2014, compared with net loss of $17.4 million in the prior year quarter. Gaap net loss per share was at $0.56 per basic and diluted share against $0.42 per share reported last year. Loss from operations was $32,232,000 compared to $20,672,000 a year ago. Net loss (non-GAAP) per share was at $0.43 per basic and diluted share compared to $0.28 per basic and diluted share a year ago. For the six months period, the company reported total revenues of $28,330,000 compared to $17,855,000 a year ago. Loss from operations was $64,673,000 compared to $44,032,000 a year ago. Net loss was $77,598,000 or $1.07 per basic and diluted share compared to $52,350,000 or $0.85 per basic and diluted share a year ago. Net loss (non-GAAP) was $63,402,000 or $0.87 per basic and diluted share compared to $38,862,000 or $0.63 per basic and diluted share a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SZYM:US $9.38 USD +0.34

SZYM Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Amyris Inc $4.22 USD +0.12
Balchem Corp $51.44 USD +0.39
Gevo Inc $0.52 USD +0.0492
Koninklijke Wessanen NV €4.23 EUR -0.016
Pacific Ethanol Inc $23.11 USD +0.64
View Industry Companies
 

Industry Analysis

SZYM

Industry Average

Valuation SZYM Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 14.2x
Price/Book 4.5x
Price/Cash Flow NM Not Meaningful
TEV/Sales 4.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SOLAZYME INC, please visit www.solazyme.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.